New Delhi: The Directorate General of Foreign Trade (DGFT) on Monday removed the restrictions on export of 12 active pharmaceutical ingredients and their formulations, reflecting the resumption of supply from factories of these bulk drugs in China.
The 12 drugs, which were put under restrictions last month, are tinidazole, metronidazole, acyclovir, vitamins B1, B6 and B12, progesterone, chloramphenicol, erythromycin and clindamycin salts, neomycin and ornidazole.
These active pharmaceutical ingredients were manufactured in the Hubei province of China, the epicentre of the novel coronavirus infection, or Covid-19.